• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An informatics-based tool to assist researchers in initiating research at an academic medical center: Vanderbilt Customized Action Plan.一种基于信息学的工具,旨在帮助研究人员在学术医疗中心开展研究:范德比尔特个性化行动计划。
Acad Med. 2010 Jan;85(1):164-8. doi: 10.1097/ACM.0b013e3181c481bf.
2
A program to provide regulatory support for investigator-initiated clinical research.一项为研究者发起的临床研究提供监管支持的计划。
Acad Med. 2006 Feb;81(2):146-53. doi: 10.1097/00001888-200602000-00007.
3
Integrating best evidence into patient care: a process facilitated by a seamless integration with informatics tools.将最佳证据融入患者护理:通过与信息学工具的无缝整合来实现这一过程。
J Med Libr Assoc. 2010 Jul;98(3):220-2. doi: 10.3163/1536-5050.98.3.009.
4
American Society of Clinical Oncology policy statement: oversight of clinical research.美国临床肿瘤学会政策声明:临床研究监督
J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29.
5
Development and Optimization of Clinical Informatics Infrastructure to Support Bioinformatics at an Oncology Center.开发和优化临床信息学基础设施,以支持肿瘤中心的生物信息学。
Methods Mol Biol. 2021;2194:1-19. doi: 10.1007/978-1-0716-0849-4_1.
6
Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals.食品和药物管理局对新放射性药物的测试和批准要求。
Semin Nucl Med. 2010 Sep;40(5):364-84. doi: 10.1053/j.semnuclmed.2010.05.002.
7
Advancing a Vision for Regulatory Science Training.推进监管科学培训的愿景。
Clin Transl Sci. 2015 Oct;8(5):615-8. doi: 10.1111/cts.12298. Epub 2015 Jun 17.
8
Centralized oversight of physician-scientist faculty development at Vanderbilt: early outcomes.范德堡大学对医师 - 科学家教师发展的集中监督:早期成果
Acad Med. 2008 Oct;83(10):969-75. doi: 10.1097/ACM.0b013e3181850950.
9
Fraud, conflict of interest, and other enforcement issues in clinical research.临床研究中的欺诈、利益冲突及其他执法问题。
Cleve Clin J Med. 2007 Mar;74 Suppl 2:S63-7; discussion S68-9. doi: 10.3949/ccjm.74.suppl_2.s63.
10
Perestroika in pharma: evolution or revolution in drug development?制药行业的改革:药物研发的进化还是革命?
Mt Sinai J Med. 2010 Jul-Aug;77(4):327-32. doi: 10.1002/msj.20198.

引用本文的文献

1
and the risk of adverse renal outcomes in patients of African ancestry with systemic lupus erythematosus.并探讨非洲裔系统性红斑狼疮患者不良肾脏结局的风险。
Lupus. 2023 May;32(6):763-770. doi: 10.1177/09612033231172660. Epub 2023 Apr 27.
2
StarBRITE: the Vanderbilt University Biomedical Research Integration, Translation and Education portal.StarBRITE:范德堡大学生物医学研究整合、转化和教育门户。
J Biomed Inform. 2011 Aug;44(4):655-62. doi: 10.1016/j.jbi.2011.01.014. Epub 2011 Feb 15.
3
Proven processes: The Vanderbilt Institute for clinical and translational research .经过验证的流程:范德比尔特临床与转化研究中心
Clin Transl Sci. 2009 Jun;2(3):180-2. doi: 10.1111/j.1752-8062.2008.00113.x.

本文引用的文献

1
Use of informatics and information technologies in the clinical research enterprise within US academic medical centers: progress and challenges from 2005 to 2007.美国学术医疗中心临床研究机构中信息学与信息技术的应用:2005年至2007年的进展与挑战
J Investig Med. 2008 Jun;56(5):770-9. doi: 10.2310/JIM.0b013e3175d7b4.
2
Viewpoint: developing a research ethics consultation service to foster responsive and responsible clinical research.观点:发展研究伦理咨询服务以促进积极且负责的临床研究
Acad Med. 2007 Sep;82(9):900-4. doi: 10.1097/ACM.0b013e318132f0ee.
3
Institutional review board approval: why it matters.机构审查委员会批准:为何重要。
J Bone Joint Surg Am. 2007 Feb;89(2):418-26. doi: 10.2106/JBJS.F.00362.
4
A program to provide regulatory support for investigator-initiated clinical research.一项为研究者发起的临床研究提供监管支持的计划。
Acad Med. 2006 Feb;81(2):146-53. doi: 10.1097/00001888-200602000-00007.
5
Translational and clinical science--time for a new vision.转化医学与临床科学——开启新视野之时。
N Engl J Med. 2005 Oct 13;353(15):1621-3. doi: 10.1056/NEJMsb053723. Epub 2005 Oct 12.

一种基于信息学的工具,旨在帮助研究人员在学术医疗中心开展研究:范德比尔特个性化行动计划。

An informatics-based tool to assist researchers in initiating research at an academic medical center: Vanderbilt Customized Action Plan.

机构信息

Vanderbilt Institute for Clinical and Translational Research (VICTR), Vanderbilt University Medical Center, Nashville, Tennessee 37203, USA.

出版信息

Acad Med. 2010 Jan;85(1):164-8. doi: 10.1097/ACM.0b013e3181c481bf.

DOI:10.1097/ACM.0b013e3181c481bf
PMID:20042844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3767144/
Abstract

The regulatory review and approval process is a significant part of the workflow associated with initiating clinical and translational research projects. Ambiguity concerning submission requirements and expected times associated with the review process can create additional work for research teams and ultimately delay important scientific projects. In an effort to provide assistance to investigators, we have developed an online interactive interface which elicits basic study characteristics for a single project and subsequently produces a list of required administrative applications needed for approval along with clear instructions concerning expectations from the research team. This system, the Vanderbilt Customized Action Plan (V-CAP), was launched in October 2006 and has been well received by researchers. In this article, the authors present (1) the V-CAP project design, (2) a reference workflow associated with Vanderbilt policies and regulations, (3) the V-CAP metrics of use by Vanderbilt research teams, and (4) a list of recommendations for other academic centers considering a similar systems-based approach for helping researchers efficiently navigate processes related to regulatory approval. The informatics-systems-based approach of the V-CAP is scalable to other academic medical centers and may serve as a useful model to help researchers navigate the complexity of the regulatory approvals process.

摘要

监管审查和审批流程是启动临床和转化研究项目相关工作流程的重要组成部分。提交要求和审查流程预期时间的不明确可能会给研究团队增加额外的工作,并最终延迟重要的科学项目。为了帮助研究人员,我们开发了一个在线交互界面,该界面可以为单个项目引出基本的研究特征,并随后生成一份批准所需的行政申请清单,并附有关于研究团队期望的明确说明。这个系统,范德比尔特定制行动计划(V-CAP),于 2006 年 10 月推出,受到了研究人员的好评。在本文中,作者介绍了(1)V-CAP 项目设计,(2)与范德比尔特政策和规定相关的参考工作流程,(3)V-CAP 被范德比尔特研究团队使用的指标,以及(4)对其他考虑采用类似基于系统的方法来帮助研究人员高效地处理与监管批准相关流程的学术中心的建议列表。V-CAP 的基于信息学系统的方法可扩展到其他学术医疗中心,并可能成为帮助研究人员应对监管批准过程复杂性的有用模型。